physician payment sunshine act
Posted in Physician Payment Sunshine Act on May 23, 2013
In the first part of our Physician Payment Sunshine Act blog series, the experienced pharmaceutical litigation lawyers at Robinson Calcagnie Robinson Shapiro Davis, Inc. discussed existing disclosure laws of several jurisdictions. The disclosure of high-cost gifts was one of the stipulations of these laws, but there are also states which have established laws banning certain…
read more
Posted in Physician Payment Sunshine Act on May 20, 2013
The Patient Protection and Affordable Care Act of 2010 includes, among its provisions, the Physician Payment Sunshine Act (PPSA), which generally requires that pharmaceutical companies disclose payments to physicians for the marketing of their products. It is the first Congressional effort in the regulation of disclosure-related pharmaceutical marketing. The PPSA took effect in January 2012,…
read more
Posted in Physician Payment Sunshine Act on February 20, 2013
For years, the pharmaceutical industry has targeted physicians and teaching hospitals to help them market their products. Drug companies provide free samples of their product for physician’s to use and offer lucrative opportunities for those who promote their drug, including gifts, dining and entertainment, lecturing opportunities in resort destinations and other forms of payment. This…
read more
